R1 RCM Acquires Cloudmed

Cloudmed Acquires Managed Care Revenue Consulting Group (MCRC Group)

July 8, 2021

Healthcare Services

Cloudmed, a healthcare revenue intelligence company based in Atlanta, acquired Managed Care Revenue Consulting Group (MCRC Group), a New York City-based provider of managed care and revenue cycle consulting services. The acquisition combines MCRC's managed care and payment validation expertise with Cloudmed's Revenue Intelligence platform to expand Cloudmed's revenue recovery and managed care capabilities for hospitals and health systems.

RCM Holdings (Edgewater) Acquires MedData from MEDNAX

February 2, 2020

Healthcare Services

Edgewater Growth Capital’s newly formed portfolio company RCM Holdings, LLC has acquired MedData, a national provider of technology-enabled revenue cycle management services, from MEDNAX, Inc. The deal creates a PE-backed RCM platform aimed at consolidating niche revenue cycle management capabilities and expanding geographic presence and service offerings to hospitals, health systems and physician groups.

R1 RCM Acquires SCI Solutions

April 1, 2020

Healthcare Services

R1 RCM Inc. completed the acquisition of SCI Solutions, a provider of digital patient access and engagement software, to expand its technology-enabled revenue cycle and patient intake capabilities. The deal (announced Jan 2020, closed Apr 2020) brings SCI’s EHR-agnostic care coordination marketplace and digital “front door” offerings into R1’s platform, and was previously owned by investors including The Wicks Group, NEA and Columbia Pacific.

Medusind Acquires RC McLean & Associates' Revenue Cycle Management Agreements

July 6, 2021

Healthcare Services

Medusind has acquired the revenue cycle management (RCM) agreements of RC McLean & Associates, a California-based anesthesia billing and practice management firm established in 1983. The deal expands Medusind's presence in Southern California and brings additional anesthesia and specialty clients onto its technology-enabled RCM platform.

R1 RCM Acquires Acclara from Providence

December 6, 2023

Healthcare Services

R1 RCM Inc. has entered into a definitive agreement to acquire Acclara from Providence for $675 million in cash plus warrants to purchase 12.2 million shares of R1. The deal includes a 10-year revenue cycle management agreement whereby Acclara and Providence will partner with R1, expanding R1's scale, capabilities, and long-term revenue opportunities in healthcare revenue cycle management.

TowerBrook and CD&R Acquire R1 RCM for $8.9 Billion

August 1, 2024

Healthcare Services

Investment funds affiliated with TowerBrook Capital Partners and Clayton, Dubilier & Rice agreed to acquire all outstanding shares of R1 RCM Inc. in an all-cash transaction valuing the company at approximately $8.9 billion ($14.30 per share). The transaction will take R1 private to support continued investment in its revenue-cycle automation platform and expansion of intelligent automation and generative AI capabilities for healthcare providers.